Importance of the stem cell microenvironment for ophthalmological cell-based therapy

被引:26
|
作者
Wan, Peng-Xia [1 ]
Wang, Bo-Wen [2 ]
Wang, Zhi-Chong [2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China
来源
WORLD JOURNAL OF STEM CELLS | 2015年 / 7卷 / 02期
关键词
Microenvironment; Niche; Stem cell; Cell-based therapy; Ocular diseases; Ophthalmology;
D O I
10.4252/wjsc.v7.i2.448
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Cell therapy is a promising treatment for diseases that are caused by cell degeneration or death. The cells for clinical transplantation are usually obtained by culturing healthy allogeneic or exogenous tissue in vitro. However, for diseases of the eye, obtaining the adequate number of cells for clinical transplantation is difficult due to the small size of tissue donors and the frequent needs of long-term amplification of cells in vitro, which results in low cell viability after transplantation. In addition, the transplanted cells often develop fibrosis or degrade and have very low survival. Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPS) are also promising candidates for cell therapy. Unfortunately, the differentiation of ESCs can bring immune rejection, tumorigenicity and undesired differentiated cells, limiting its clinical application. Although iPS cells can avoid the risk of immune rejection caused by ES cell differentiation post-transplantation, the low conversion rate, the risk of tumor formation and the potentially unpredictable biological changes that could occur through genetic manipulation hinder its clinical application. Thus, the desired clinical effect of cell therapy is impaired by these factors. Recent research findings recognize that the reason for low survival of the implanted cells not only depends on the seeded cells, but also on the cell microenvironment, which determines the cell survival, proliferation and even reverse differentiation. When used for cell therapy, the transplanted cells need a specific three-dimensional structure to anchor and specific extra cellular matrix components in addition to relevant cytokine signaling to transfer the required information to support their growth. These structures present in the matrix in which the stem cells reside are known as the stem cell microenvironment. The microenvironment interaction with the stem cells provides the necessary homeostasis for cell maintenance and growth. A large number of studies suggest that to explore how to reconstruct the stem cell microenvironment and strengthen its combination with the transplanted cells are key steps to successful cell therapy. In this review, we will describe the interactions of the stem cell microenvironment with the stem cells, discuss the importance of the stem cell microenvironment for cell-based therapy in ocular diseases, and introduce the progress of stem cell-based therapy for ocular diseases.
引用
收藏
页码:448 / 460
页数:13
相关论文
共 50 条
  • [41] Stem Cell-Based Therapy for Coronavirus Disease 2019
    Zhao, Robert Chunhua
    STEM CELLS AND DEVELOPMENT, 2020, 29 (11) : 679 - 681
  • [42] In vivo tracking in cardiac stem cell-based therapy
    Hoshino, Kozo
    Ly, Hung Q.
    Frangioni, John V.
    Hajjar, Roger J.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2007, 49 (06) : 414 - 420
  • [43] Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis
    Sarsenova, Madina
    Issabekova, Assel
    Abisheva, Saule
    Rutskaya-Moroshan, Kristina
    Ogay, Vyacheslav
    Saparov, Arman
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [44] Stem cell-based therapy for inflammatory bowel disease
    Shimizu, Hiromichi
    Suzuki, Kohei
    Watanabe, Mamoru
    Okamoto, Ryuichi
    INTESTINAL RESEARCH, 2019, 17 (03) : 311 - 316
  • [45] Editorial: Stem Cell-Based Therapy in Retinal Degeneration
    Huang, Xiaona
    Gao, Hui
    Xu, Haiwei
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [46] Ethical and Safety Issues of Stem Cell-Based Therapy
    Volarevic, Vladislav
    Markovic, Bojana Simovic
    Gazdic, Marina
    Volarevic, Ana
    Jovicic, Nemanja
    Arsenijevic, Nebojsa
    Armstrong, Lyle
    Djonov, Valentin
    Lako, Majlinda
    Stojkovic, Miodrag
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2018, 15 (01): : 36 - 45
  • [47] Stem cell-based therapy for COVID-19
    Chen, Xiaomei
    Liu, Bowen
    Li, Chao
    Wang, Yulian
    Geng, Suxia
    Du, Xin
    Weng, Jianyu
    Lai, Peilong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [48] Neural stem cells for diabetes cell-based therapy
    Basak, Onur
    Clevers, Hans
    EMBO MOLECULAR MEDICINE, 2011, 3 (12) : 698 - 700
  • [49] Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis
    Barczyk, Marek
    Schmidt, Matthias
    Mattoli, Sabrina
    STEM CELL REVIEWS AND REPORTS, 2015, 11 (04) : 598 - 620
  • [50] Mesenchymal stem cell-based therapy for ischemic stroke
    Anderson J.D.
    Pham M.T.
    Contreras Z.
    Hoon M.
    Fink K.D.
    Johansson H.J.
    Rossignol J.
    Dunbar G.L.
    Showalter M.
    Fiehn O.
    Bramlett C.S.
    Bardini R.L.
    Bauer G.
    Fury B.
    Hendrix K.J.
    Chedin F.
    El-Andaloussi S.
    Hwang B.
    Mulligan M.S.
    Lehtiö J.
    Nolta J.A.
    Chinese Neurosurgical Journal, 2 (1)